Noriyuki Masuda Selected Research

Noriyuki Masuda Research Topics

Disease

46	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 06/2005
23	Neoplasms (Cancer) 11/2018 - 04/2004
19	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2018 - 01/2003
14	Adenocarcinoma of Lung 11/2019 - 03/2010
14	Lung Neoplasms (Lung Cancer) 04/2018 - 06/2005
9	Neoplasm Metastasis (Metastasis) 11/2018 - 04/2004
9	Adenocarcinoma 04/2018 - 11/2006
9	Carcinoma (Carcinomatosis) 12/2015 - 09/2009
8	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 11/2006
7	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2019 - 09/2008
6	Neutropenia 01/2018 - 01/2003
4	Disease Progression 01/2018 - 12/2006
4	Febrile Neutropenia 10/2017 - 04/2012
4	Small Cell Carcinoma 01/2015 - 11/2007
3	Infections 08/2015 - 04/2012
3	Leukopenia 08/2015 - 01/2003
3	Pneumonia (Pneumonitis) 04/2012 - 09/2008
2	Urologic Diseases (Urinary Tract Disease) 06/2019 - 03/2019
2	Pain (Aches) 01/2018 - 01/2016
2	Pneumothorax 05/2017 - 01/2017
2	Hypertension (High Blood Pressure) 01/2017 - 07/2011
2	Thrombocytopenia (Thrombopenia) 01/2017 - 01/2003
2	Bronchiectasis 01/2017 - 07/2011
2	Hypercapnia 12/2016 - 01/2015
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2015 - 04/2009
2	Diarrhea 03/2012 - 10/2008
2	Anemia 06/2009 - 01/2003
1	COVID-19 01/2023
1	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 07/2022
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 06/2019
1	Drug-Related Side Effects and Adverse Reactions 04/2019
1	Brain Neoplasms (Brain Tumor) 04/2019
1	Pleural Effusion (Pleural Effusions) 01/2019
1	Pulmonary Edema 01/2019
1	Hyperplasia 01/2018

Drug/Important Bio-Agent (IBA)

14	ErbB Receptors (EGF Receptor)IBA 01/2021 - 08/2005
12	amrubicinIBA 01/2021 - 06/2005
10	Irinotecan (Camptosar)FDA LinkGeneric 01/2017 - 06/2005
9	Carboplatin (JM8)FDA LinkGeneric 01/2020 - 11/2010
8	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021 - 02/2010
8	PlatinumIBA 01/2018 - 06/2005
8	Gefitinib (Iressa)FDA Link 01/2015 - 08/2005
7	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 01/2011
7	Docetaxel (Taxotere)FDA Link 01/2020 - 06/2005
7	Tyrosine Kinase InhibitorsIBA 01/2019 - 02/2010
7	Proteins (Proteins, Gene)FDA Link 01/2017 - 02/2010
6	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 06/2005
5	130-nm albumin-bound paclitaxelIBA 01/2018 - 05/2014
5	Pemetrexed (MTA)FDA Link 05/2017 - 01/2012
4	Monoclonal AntibodiesIBA 04/2018 - 07/2010
3	CrizotinibIBA 09/2019 - 01/2019
3	AntigensIBA 04/2018 - 01/2012
3	NestinIBA 01/2017 - 04/2011
3	AutoantibodiesIBA 01/2015 - 06/2012
3	ParaffinIBA 12/2011 - 02/2010
3	Formaldehyde (Formol)FDA Link 12/2011 - 02/2010
3	Topotecan (Hycamtin)FDA LinkGeneric 10/2011 - 01/2003
3	Gemcitabine FDA Link 01/2011 - 06/2005
2	Adrenergic Receptors (Adrenergic Receptor)IBA 07/2022 - 05/2016
2	Midodrine (Midon)FDA LinkGeneric 07/2022 - 05/2016
2	Immunoglobulin G (IgG)IBA 01/2021 - 11/2006
2	Anaplastic Lymphoma KinaseIBA 09/2019 - 01/2016
2	ASP6432IBA 06/2019 - 03/2019
2	alectinibIBA 04/2019 - 01/2016
2	NivolumabIBA 11/2018 - 01/2017
2	Indicators and Reagents (Reagents)IBA 04/2018 - 02/2013
2	nedaplatinIBA 01/2018 - 12/2015
2	Bevacizumab (Avastin)FDA Link 01/2018 - 12/2012
2	SteroidsIBA 01/2017 - 12/2016
2	Cadherins (E-Cadherin)IBA 01/2017 - 11/2006
2	Aminophylline (Carine)FDA LinkGeneric 12/2016 - 01/2015
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2016 - 06/2012
2	Biomarkers (Surrogate Marker)IBA 02/2013 - 07/2010
2	Topoisomerase II InhibitorsIBA 06/2012 - 12/2006
2	Topoisomerase I InhibitorsIBA 06/2012 - 07/2010
2	Vinorelbine (Navelbine)FDA LinkGeneric 04/2012 - 06/2005
2	7-ethyl-10-hydroxycamptothecin beta-glucuronideIBA 03/2012 - 10/2008
2	GlucuronidaseIBA 03/2012 - 10/2008
2	Hemoglobins (Hemoglobin)IBA 06/2009 - 01/2003
2	CytokinesIBA 12/2008 - 04/2004
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2008 - 04/2004
1	BNT162 VaccineIBA 01/2023
1	mRNA VaccinesIBA 01/2023
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 07/2022
1	Atropine FDA LinkGeneric 07/2022
1	nimotuzumabIBA 01/2021
1	Small Interfering RNA (siRNA)IBA 11/2019
1	Immune Checkpoint InhibitorsIBA 11/2018
1	B7-H1 AntigenIBA 11/2018
1	osimertinibIBA 06/2018
1	Glycoproteins (Glycoprotein)IBA 04/2018
1	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 04/2018

Therapy/Procedure

30	Drug Therapy (Chemotherapy) 06/2019 - 06/2005
18	Therapeutics 06/2019 - 06/2005
4	Radiotherapy 01/2017 - 02/2007
3	Adjuvant Chemotherapy 01/2020 - 01/2017
3	Aftercare (After-Treatment) 01/2019 - 12/2006
2	Chemoradiotherapy 01/2021 - 07/2017
2	Cranial Irradiation 01/2018 - 09/2015
2	Traction 01/2017 - 07/2011